Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-004852-39Phase 3Active
Phase 3, randomised, double-blind trial in gastrointestinal cancer comparing Corticosteroids arm with Placebo arm (2 arms). Primary endpoint: Major postoperative complications at 30 days. Started Mar 2019; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-004852-39.